CHICAGO, Oct 16 (Reuters) - Shares of medical device maker Medtronic Inc tumbled to their lowest price in more than six years on Thursday after a study showed that its new drug-coated stent was associated with more heart attacks and blood clots than a rival stent made by Johnson & Johnson.
